<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>275</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15519708</PubmedId>
            <Abstract>Virus specific T cell responses play an important role in resolving acute hepatitis C virus (HCV) infections. Using the HLA-A2.1 transgenic mouse model we investigated the potential of a liposomal peptide vaccine to prime a CD8(+) T cell response against 10 different HCV epitopes, relevant for human applications. We were able to demonstrate the induction of strong cytotoxic T cell responses and high numbers of IFN-gamma-secreting cells, which persisted at high levels for at least 3 months. Co-integrating CpG oligonucleotides into liposomes further increased the number of IFN-gamma-secreting cells by 2-10-fold for most epitopes tested. The frequency of specific cells was further analysed with chimeric A2 tetramers bearing the NS31073-1081 epitope and was estimated at 2-23% of the CD8(+) T cell population. Importantly, mouse effector cells, specific for this epitope, were also capable of lysing a human target cell line expressing HCV proteins. This finding and the specific protection observed in challenge experiments with recombinant vaccinia virus expressing HCV sequences emphasise the biological relevance of the vaccine-induced immune response. In conclusion, such liposome formulations represent a safe and promising strategy to stimulate the CD8(+) T cell against HCV.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>58-68</ArticlePages>
            <ArticleTitle>A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Engler</LastName>
                    <ForeName>Olivier B</ForeName>
                </Author>
                <Author>
                    <LastName>Schwendener</LastName>
                    <ForeName>Reto A</ForeName>
                </Author>
                <Author>
                    <LastName>Dai</LastName>
                    <ForeName>Wen Juan</ForeName>
                </Author>
                <Author>
                    <LastName>Wölk</LastName>
                    <ForeName>Benno</ForeName>
                </Author>
                <Author>
                    <LastName>Pichler</LastName>
                    <ForeName>Werner</ForeName>
                </Author>
                <Author>
                    <LastName>Moradpour</LastName>
                    <ForeName>Darius</ForeName>
                </Author>
                <Author>
                    <LastName>Brunner</LastName>
                    <ForeName>Thomas</ForeName>
                </Author>
                <Author>
                    <LastName>Cerny</LastName>
                    <ForeName>Andreas</ForeName>
                </Author>
            </Authors>
            <Affiliations>Clinic for Rheumatology and Clinical Immunology/Allergology, Inselspital, Bern, Switzerland.</Affiliations>
            <ArticleChemicalList>HLA-A2 Antigen;Liposomes;Vaccines, Subunit;Vaccines, Synthetic</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; CD8-Positive T-Lymphocytes(immunology); Cell Line; HLA-A2 Antigen(genetics; immunology); Hepacivirus(genetics; immunology); Hepatitis, Animal(immunology); Humans; Liposomes; Mice; Mice, Transgenic; Vaccines, Subunit(immunology); Vaccines, Synthetic(immunology); Vaccinia(genetics)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>23</Volume>
                <Issue>1</Issue>
                <Title>Vaccine</Title>
                <Issn>0264-410X</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Core 35</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLLPRRGPRL</LinearSequence>
                        <StartingPosition>35</StartingPosition>
                        <EndingPosition>44</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>74798</EpitopeId>
                <ReferenceStartingPosition>35</ReferenceStartingPosition>
                <ReferenceEndingPosition>44</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361190</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLLPRRGPRL</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>44</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 35</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core 35</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLLPRRGPRL</LinearSequence>
                                        <StartingPosition>35</StartingPosition>
                                        <EndingPosition>44</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response 10-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361189</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLLPRRGPRL</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>44</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 35</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLLPRRGPRL</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>44</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core 35</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLLPRRGPRL</LinearSequence>
                                        <StartingPosition>35</StartingPosition>
                                        <EndingPosition>44</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a very low CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. However, co-integration of CpG into the liposomes moderately enhanced the CTL response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1361205</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>143</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLLPRRGPRL</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>44</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 35</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 2 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope and CpG.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eleven days after immunization mice were challenged  i.p. with 10^7 pfu recombinant vaccinia virus vv9A encoding the full-length HCV core protein and part of the E1 protein (residues 1-339). Ovaries were removed 5 days post infection for assay of viral loads.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>HCV core protein</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <RecombinantOrganism>
                                    <SubType>Recombinant Organism</SubType>
                                    <RecombinantOrganismId>10245</RecombinantOrganismId>
                                </RecombinantOrganism>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope and CpG encapsulated in liposomes did not reduce the viral load after challenge with recombinant vaccinia virus vv9a expressing HCV core sequences. Viral loads were assessed in the ovaries 5 days after infection. The epitope was also a poor inducer of a CTL response assayed in vitro.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Core 132</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DLMGYIPLV</LinearSequence>
                        <StartingPosition>132</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>9203</EpitopeId>
                <ReferenceStartingPosition>132</ReferenceStartingPosition>
                <ReferenceEndingPosition>140</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>47</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLMGYIPLV</LinearSequence>
                                            <StartingPosition>132</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 132</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLMGYIPLV</LinearSequence>
                                            <StartingPosition>132</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core 132</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DLMGYIPLV</LinearSequence>
                                        <StartingPosition>132</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced CTL that lysed HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Incorporation of the universal T helper epitope PADRE into the liposomes or coupled to the surface did not further enhance the response, although the PADRE epitope was shown to prime T helper cells. Co-integration of CpG molecules into the liposomes augmented lysis at low effector to target  ratios.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Text p. 64</LocationOfData>
                        <TCellId>1361212</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLMGYIPLV</LinearSequence>
                                            <StartingPosition>132</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 132</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core 132</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DLMGYIPLV</LinearSequence>
                                        <StartingPosition>132</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1361206</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>143</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLMGYIPLV</LinearSequence>
                                            <StartingPosition>132</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core 132</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 2 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope and CpG.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eleven days after immunization mice were challenged  i.p. with 10^7 pfu recombinant vaccinia virus vv9A encoding the full-length HCV core protein and part of the E1 protein (residues 1-339). Ovaries were removed 5 days post infection for assay of viral loads.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV core protein</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <RecombinantOrganism>
                                    <SubType>Recombinant Organism</SubType>
                                    <RecombinantOrganismId>10245</RecombinantOrganismId>
                                </RecombinantOrganism>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope and CpG encapsulated in liposomes reduced the viral load (1.5-2 log reduction) after challenge with recombinant vaccinia virus vv9a expressing HCV core sequences. Viral loads were assessed in the ovaries 5 days after infection. The epitope was also capable of inducing a strong CTL response assayed in vitro.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>E2 614</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLWHYPCTI</LinearSequence>
                        <StartingPosition>614</StartingPosition>
                        <EndingPosition>622</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>54821</EpitopeId>
                <ReferenceStartingPosition>614</ReferenceStartingPosition>
                <ReferenceEndingPosition>622</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361191</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLWHYPCTI</LinearSequence>
                                            <StartingPosition>614</StartingPosition>
                                            <EndingPosition>622</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E2 614</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLWHYPCTI</LinearSequence>
                                            <StartingPosition>614</StartingPosition>
                                            <EndingPosition>622</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E2 614</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLWHYPCTI</LinearSequence>
                                        <StartingPosition>614</StartingPosition>
                                        <EndingPosition>622</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a moderate CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes enhanced the CTL response at low effector to target cell ratios.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361192</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLWHYPCTI</LinearSequence>
                                            <StartingPosition>614</StartingPosition>
                                            <EndingPosition>622</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E2 614</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E2 614</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLWHYPCTI</LinearSequence>
                                        <StartingPosition>614</StartingPosition>
                                        <EndingPosition>622</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response 10-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>E2 686</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ALSTGLIHL</LinearSequence>
                        <StartingPosition>684</StartingPosition>
                        <EndingPosition>692</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>2901</EpitopeId>
                <ReferenceStartingPosition>686</ReferenceStartingPosition>
                <ReferenceEndingPosition>694</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361193</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ALSTGLIHL</LinearSequence>
                                            <StartingPosition>684</StartingPosition>
                                            <EndingPosition>692</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E2 686</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ALSTGLIHL</LinearSequence>
                                            <StartingPosition>684</StartingPosition>
                                            <EndingPosition>692</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E2 686</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALSTGLIHL</LinearSequence>
                                        <StartingPosition>684</StartingPosition>
                                        <EndingPosition>692</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a strong CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes enhanced the CTL response at low effector to target cell ratios.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361194</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ALSTGLIHL</LinearSequence>
                                            <StartingPosition>684</StartingPosition>
                                            <EndingPosition>692</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E2 686</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E2 686</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALSTGLIHL</LinearSequence>
                                        <StartingPosition>684</StartingPosition>
                                        <EndingPosition>692</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes did not significantly stimulate IFN-γ-secreting cells. However, co-integration of CpG into the liposomes increased the response. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS3 1073</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CINGVCWTV</LinearSequence>
                        <StartingPosition>1073</StartingPosition>
                        <EndingPosition>1081</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>6435</EpitopeId>
                <ReferenceStartingPosition>1073</ReferenceStartingPosition>
                <ReferenceEndingPosition>1081</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1361145</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1073</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1073</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CINGVCWTV</LinearSequence>
                                        <StartingPosition>1073</StartingPosition>
                                        <EndingPosition>1081</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The frequency of IFN-γ-producing cells was 0.6% of splenocytes (11% of CD8+ T cells) from HLA-A2.1-transgenic mice immunized with the epitope encapsulated in liposomes and 5% of total splenocytes (31 % of CD8+ T cells) from mice immunized with liposomes containing the epitope and CpG. ELISPOT assays showed that high numbers of IFN-γ-secreting cells were induced 2 weeks and 3 months after immunization, indicating the efficient primimg of memory cells. Immunization with immunized with liposomes containing the epitope and CpG increased the number of IFN-γ-secreting cells observed at 3 months.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1361126</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1073</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added. Spleen cells were also taken 3 months after the last injection and treated similarly to assay the memory response.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1073</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CINGVCWTV</LinearSequence>
                                        <StartingPosition>1073</StartingPosition>
                                        <EndingPosition>1081</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced CTL that lysed HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Incorporation of the T helper epitope HBV core 128 or CpG into the liposomes did not further enhance the response. The CTL response was still high after 3 months indicating the immunization primed memory T cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1361134</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1073</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added. Spleen cells were also taken 3 months after the last injection and treated similarly to assay the memory response.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3-4A</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced CTL that lysed the HLA-A*0201-expressing cell line T1/NS3-4A transfected with the NS3-4A gene. The authors conclude that the epitope-specific CTL recognized the endogenously processed and expressed NS3 epitope. Co-integration of CpG into the liposomes did not further enhance the response. Incorporation of the T helper epitope HBV core 128 into the liposomes with the epitope induced CTL that lysed targets inefficiently. The CTL response was still high 3 months after immunization with the epitope with or without CpG, indicating that memory T cells were primed.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1361140</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1073</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1073</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CINGVCWTV</LinearSequence>
                                        <StartingPosition>1073</StartingPosition>
                                        <EndingPosition>1081</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The frequency of epitope-specific cells 14 days after immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes was 2 % of the CD8+ T cells. Immunization with the epitope and CpG incoroporated into the liposomes increased the frequency of tetramer positive CD8+ T cells to 22%.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS3 1169</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLCPAGHAV</LinearSequence>
                        <StartingPosition>1169</StartingPosition>
                        <EndingPosition>1177</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>37127</EpitopeId>
                <ReferenceStartingPosition>1169</ReferenceStartingPosition>
                <ReferenceEndingPosition>1177</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361196</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLCPAGHAV</LinearSequence>
                                            <StartingPosition>1169</StartingPosition>
                                            <EndingPosition>1177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1169</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1169</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLCPAGHAV</LinearSequence>
                                        <StartingPosition>1169</StartingPosition>
                                        <EndingPosition>1177</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes very weakly stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361195</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLCPAGHAV</LinearSequence>
                                            <StartingPosition>1169</StartingPosition>
                                            <EndingPosition>1177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1169</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLCPAGHAV</LinearSequence>
                                            <StartingPosition>1169</StartingPosition>
                                            <EndingPosition>1177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1169</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLCPAGHAV</LinearSequence>
                                        <StartingPosition>1169</StartingPosition>
                                        <EndingPosition>1177</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a strong CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes enhanced the CTL response at low effector to target cell ratios.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS3 1406</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KLVALGINAV</LinearSequence>
                        <StartingPosition>1406</StartingPosition>
                        <EndingPosition>1415</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>32208</EpitopeId>
                <ReferenceStartingPosition>1406</ReferenceStartingPosition>
                <ReferenceEndingPosition>1416</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361197</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLVALGINAV</LinearSequence>
                                            <StartingPosition>1406</StartingPosition>
                                            <EndingPosition>1415</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1406</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLVALGINAV</LinearSequence>
                                            <StartingPosition>1406</StartingPosition>
                                            <EndingPosition>1415</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1406</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KLVALGINAV</LinearSequence>
                                        <StartingPosition>1406</StartingPosition>
                                        <EndingPosition>1415</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a very low CTL response in against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Only one of 3 mice showed a measurable response. Co-integration of CpG into the liposomes enhanced the CTL response in 3 mice tested.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361198</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLVALGINAV</LinearSequence>
                                            <StartingPosition>1406</StartingPosition>
                                            <EndingPosition>1415</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1406</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1406</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KLVALGINAV</LinearSequence>
                                        <StartingPosition>1406</StartingPosition>
                                        <EndingPosition>1415</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response about 3-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS3 1585</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLVAYQATV</LinearSequence>
                        <StartingPosition>1585</StartingPosition>
                        <EndingPosition>1593</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>74961</EpitopeId>
                <ReferenceStartingPosition>1585</ReferenceStartingPosition>
                <ReferenceEndingPosition>1593</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361199</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLVAYQATV</LinearSequence>
                                            <StartingPosition>1585</StartingPosition>
                                            <EndingPosition>1593</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1585</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLVAYQATV</LinearSequence>
                                            <StartingPosition>1585</StartingPosition>
                                            <EndingPosition>1593</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1585</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLVAYQATV</LinearSequence>
                                        <StartingPosition>1585</StartingPosition>
                                        <EndingPosition>1593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes did not affect the CTL response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361200</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLVAYQATV</LinearSequence>
                                            <StartingPosition>1585</StartingPosition>
                                            <EndingPosition>1593</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS3 1585</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS3 1585</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLVAYQATV</LinearSequence>
                                        <StartingPosition>1585</StartingPosition>
                                        <EndingPosition>1593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response 10-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS4 1769</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HMWNFISGI</LinearSequence>
                        <StartingPosition>1764</StartingPosition>
                        <EndingPosition>1772</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>24357</EpitopeId>
                <ReferenceStartingPosition>1769</ReferenceStartingPosition>
                <ReferenceEndingPosition>1777</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361202</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HMWNFISGI</LinearSequence>
                                            <StartingPosition>1764</StartingPosition>
                                            <EndingPosition>1772</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS4 1769</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 1769</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HMWNFISGI</LinearSequence>
                                        <StartingPosition>1764</StartingPosition>
                                        <EndingPosition>1772</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes decreased the response about 2-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361201</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HMWNFISGI</LinearSequence>
                                            <StartingPosition>1764</StartingPosition>
                                            <EndingPosition>1772</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS4 1769</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HMWNFISGI</LinearSequence>
                                            <StartingPosition>1764</StartingPosition>
                                            <EndingPosition>1772</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 1769</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HMWNFISGI</LinearSequence>
                                        <StartingPosition>1764</StartingPosition>
                                        <EndingPosition>1772</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a moderate CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes decreased the CTL response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS4 1851</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILAGYGAGV</LinearSequence>
                        <StartingPosition>1851</StartingPosition>
                        <EndingPosition>1859</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26664.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>31646</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>26954</EpitopeId>
                <ReferenceStartingPosition>1851</ReferenceStartingPosition>
                <ReferenceEndingPosition>1859</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361203</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILAGYGAGV</LinearSequence>
                                            <StartingPosition>1851</StartingPosition>
                                            <EndingPosition>1859</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS4 1851</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILAGYGAGV</LinearSequence>
                                            <StartingPosition>1851</StartingPosition>
                                            <EndingPosition>1859</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization and restimulated in vitro for 5 days with irradiated spleen cells pulsed with epitope and on day 2, IL-2 was added.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 1851</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILAGYGAGV</LinearSequence>
                                        <StartingPosition>1851</StartingPosition>
                                        <EndingPosition>1859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes induced a strong CTL response against HLA-A*0201-expressing EL4S3-Rob HHD target cells pulsed with the epitope. Co-integration of CpG into the liposomes enhanced the CTL response slightly at low effector to target cell ratios.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1361204</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000577</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILAGYGAGV</LinearSequence>
                                            <StartingPosition>1851</StartingPosition>
                                            <EndingPosition>1859</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26664.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>31646</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS4 1851</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>CpG</Adjuvant>
                                <Adjuvant>Liposomes</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Mice received 3 immunizations at 2-wk intervals of  the liposome formulation containing about 130 µg epitope.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Spleen cells were taken 2 weeks after the last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 1851</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILAGYGAGV</LinearSequence>
                                        <StartingPosition>1851</StartingPosition>
                                        <EndingPosition>1859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26664.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>31646</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunization of HLA-A2.1-transgenic mice with the epitope encapsulated in liposomes stimulated IFN-γ-secreting cells. Co-integration of CpG into the liposomes increased the response about 3-fold. Effector cells were restimulated overnight with irradiated splenocytes pulsed with epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

